ACADIA Pharmaceuticals Inc. news

   Watch this stock
Showing stories 1 - 10 of about 80   

Articles published

ACAD 17.55 -0.68 (-3.73%)
price chart
Recent Broker Updates On ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Recently stock market analysts have updated their consensus ratings on shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD).
ACADIA Pharmaceuticals Inc. (ACAD) Jumps 7.77% on February 09
ACADIA Pharmaceuticals Inc. (ACAD) was among the biggest gainers on the Russell 2000 for Tuesday February 09 as the stock popped 7.77% to $19.14, representing a gain of $1.38 per share.
BofA Merrill Lynch Recommends Buying Acadia Pharmaceuticals Inc.
Bank of America Merrill Lynch has initiated coverage on Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) stock with a Buy rating, which shows that the firm has a positive view on the company's pipeline products.
ACADIA Pharmaceuticals Inc. (ACAD) Now Covered by Bank of America  The Vista Voice
ACADIA Pharmaceuticals Inc. 109.5% Potential Upside Now Implied by BofA/Merrill  DirectorsTalk Interviews
Bank of America Initiates Coverage on ACADIA Pharmaceuticals Inc. to Buy
Bank of America Initiates Coverage on ACADIA Pharmaceuticals Inc.(NASDAQ:ACAD). The shares have been rated Buy. The rating by Bank of America was issued on Feb 8, 2016.
Bank of America Begins Coverage on ACADIA Pharmaceuticals Inc. (ACAD)  Intercooler Financial
Is ACADIA Pharmaceuticals Inc. a Sell? The Stock Gapped Down Today  Sonoran Weekly Review
Why Shares of ACADIA Pharmaceuticals Inc. Fell off a Cliff
What: Investors in ACADIA Pharmaceuticals (NASDAQ:ACAD), a biopharmaceutical company focused on neurological and central nervous system disorders, are having a rough day as the stock fell by more than 12% earlier this morning (although shares ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Public offering of its common shares  Inside Trade
Hottest Stocks: ACADIA Pharmaceuticals Inc., Peregrine Pharmaceuticals ...  Property Mentor
Today's Dead Cat Bounce Stock Is ACADIA Pharmaceuticals (ACAD)
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders.
ACADIA Pharmaceuticals Inc. (ACAD) Hits New 52-week Low During January 12 ...  Equities.com
Biotech Beat: Analysts Weigh In on Galena Biopharma Inc (GALE), ACADIA ...
Healthcare analysts weighed in today on cancer therapeutics firm Galena Biopharma Inc (NASDAQ:GALE), biopharmaceutical company ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and immunotherapy company Inovio Pharmaceuticals Inc ...
Stocks in News: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), WGL Holdings Inc ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), announced that it presented at the LEERINK Partners 5th Annual Global Healthcare Conference on Wednesday, February 10, 2016, at 8:00 a.m.
In the News Stocks: Tyco International plc (NYSE:TYC), Federal Realty ...  Property Mentor
Today's Dead Cat Bounce Stock: ACADIA Pharmaceuticals (ACAD)
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders.
ACADIA Pharmaceuticals Inc. (ACAD) Shares Bought by Hollencrest Securities  EMQ
Hollencrest Securities Raises Position in ACADIA Pharmaceuticals Inc. (ACAD)  IRA Market Report
Stock Update (NASDAQ:ACAD): ACADIA Pharmaceuticals Inc. Announces FDA Advisory ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced that ...